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Background: The effects of clustering in randomized controlled trials (RCTs) and the resulting potential violation of
assumptions of independence are now well recognized. When patients in a single study are treated by several
therapists, there is good reason to suspect that the variation in outcome will be smaller for patients treated in the
same group than for patients treated in different groups. This potential correlation of outcomes results in a loss of
independence of observations. The purpose of this study is to examine the current use of clustering analysis in
RCTs published in the top five journals of orthopaedic surgery.
Methods: RCTs published from 2006 to 2010 in the top five journals of orthopaedic surgery, as determined by
5-year impact factor, that included multiple therapists and/or centers were included. Identified articles were assessed
for accounting for the effects of clustering of therapists and/or centers in randomization or analysis. Logistic regression
used both univariate and multivariate models, with use of clustering analysis as the outcome. Multivariate models were
constructed using stepwise deletion. An alpha level of 0.10 was considered significant.
Results: A total of 271 articles classified as RCTs were identified from the five journals included in the study. Thirty-two
articles were excluded due to inclusion of nonhuman subjects. Of the remaining 239 articles, 186 were found to
include multiple centers and/or therapists. The prevalence of use of clustering analysis was 21.5%. Fewer than half
of the studies reported inclusion of a statistician, epidemiologist or clinical trials methodologist on the team. In
multivariate modeling, adjusting for clustering was associated with a 6.7 times higher odds of inclusion of any
type of specialist on the team (P = 0.08). Likewise, trials that accounted for clustering had 3.3 times the odds of
including an epidemiologist/clinical trials methodologist than those that did not account for clustering (P = 0.04).
Conclusions: Including specialists on a study team, especially an epidemiologist or clinical trials methodologist,
appears to be important in the decision to account for clustering in RCT reporting. The use of clustering analysis
remains an important piece of unbiased reporting, and accounting for clustering in RCTs should be a standard
reporting practice.
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The effects of clustering in randomized controlled trials
(RCTs) and the resulting potential violation of assump-
tions of independence are now well recognized [1,2]. For
example, when patients in a single study are treated by
several therapists, there may be reason to suspect that* Correspondence: jgagnier@umich.edu
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article, unless otherwise stated.the variation in outcome will be smaller between pa-
tients treated by the same clinician than between pa-
tients treated by different clinicians [2-4]. Clustering
effects may arise when there is a potential for correlation
of outcomes among patients in similar groups, which
can result in a loss of independence of observations.
Analyses taking into account correlation among patients
may be especially important for studies involving treat-
ment and care that depend on substantial skill or train-
ing; however, differential therapist effects may also arise
due to personality differences, personal experience, or
infrastructure [1,2,5,6]. Clustering may also occur byCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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patient facilities) or in a study that randomizes by cluster
(a cluster randomized trial), in which those delivering
the intervention (e.g., surgeons) represent different clus-
ters. On occasion, differences between clusters may be
an outcome of interest to researchers; however, the out-
come in RCTs is typically a measure of effectiveness of
some intervention, irrespective of any clusters. That is, if
the effectiveness of an intervention is influenced by
some cluster (e.g., the healthcare provider delivering
treatment) and if this is not measured or accounted for
in the study, this introduces a source of bias into any
outcomes measured [6]. These potential sources of bias
(e.g., center cluster or therapist cluster) have implica-
tions for outcome effect magnitudes and directions, and
thus should be recognized and treated accordingly. The
design and analysis of RCTs should account for the pos-
sible heterogeneity in cluster size and intracluster correl-
ation to appropriately analyze results [2].
The majority of statistical analyses used in RCTs are
based on the assumption that observed outcomes on dif-
ferent patients are independent [7]. Independence of ob-
servations is a basic assumption of many widely used
statistical tests, including t-tests and generalized linear
modeling. Between-cluster variation may therefore lead
to a loss of precision and reduced power when estimat-
ing treatment effects [2,6]. Clustering therefore has im-
plications for the required sample size of an RCT; the
impact depends on the study design and analysis used
[1]. The magnitude of the effect additionally depends on
cluster size and intracluster correlation coefficients
(ICCs) [2]. The extent to which the treatment effect var-
ies across clusters can have a major impact on the inter-
pretation of a trial’s results; however, there is often not
enough information to obtain a precise estimate of the
clustering effect, since most trials are not powered to de-
tect this variability [7]. The magnitude of clustering may
depend on cluster type, setting, and type of outcome, as
well as time since receiving the intervention [1]. There-
fore, if clustering is believed a priori to be a realistic
possibility, it is important to account for it in analysis to
appropriately interpret the treatment effect [7].
These effects are illustrated in a study by Lee and
Thompson [7], in which two published trials were re-
analyzed using an analysis method that accounted for
the effects of clustering, which was not used in the ori-
ginal publication. They found that if potential clustering
is ignored, uncertainty may be underestimated, produ-
cing too extreme p values and even altering the results
of a trial [7]. In their first re-analysis, the authors looked
at a trial assessing the effectiveness of teleconsultations
performed by 20 consultants. The original study ana-
lyzed the observations as independent and concluded
that the treatment was significantly more effective thanthe control. In a re-analysis of the study data using a
random effects model, Lee and Thompson [7] found that
clustering by consultant was significant. When this clus-
tering was controlled for in the model, the resulting
odds ratio became nonsignificant, therefore altering the
results of the trial. In the re-analysis of a second study,
the results of an exercise class delivered by 21 physio-
therapists were called into question when it was deter-
mined that the standard error in a model controlling for
clustering was larger than originally determined. This
suggested a wide variation in treatment effect and again
alters the interpretation of the study results.
In a second study that re-analyzed the data of two
clinical trials to account for clustering, Roberts and
Roberts [2] again found that the standard errors of the
treatment effects markedly increased. A study by Cook
et al. [1], analyzing ICCs for 198 outcomes across 10
multicenter surgical trials, demonstrated clustering ef-
fects at both the center and surgeon level and concluded
that clustering of outcome is more of an issue than has
been previously acknowledged. These examples demon-
strate the dramatic effect that clustering may have and
the mistaken conclusions that can be drawn if it is ig-
nored in the analyses.
In one study specifically assessing a large orthopaedics
surgical trial, Biau et al. [8] found provider effects to be
highly significant in re-analysis. These provider effects
were found to be more significant in highly specialized
fields, such as orthopaedics, in contrast to general sur-
gery [8]. Using volume of patients seen per surgeon as a
proxy for surgeon experience, higher surgeon experience
was shown to correlate with better patient outcomes [8].
This study therefore suggests that controlling for cluster-
ing effects is especially important in studies that involve
highly skilled therapists.
Clustering in randomized clinical trials can be dealt
with in many ways. Several methods of accounting for
clustering are widely recognized: randomizing patients
within each cluster (e.g., to the treatment provider),
cluster-level analysis, fixed-effects models, random ef-
fects models, or generalized estimating equations [6,9].
Despite multiple studies demonstrating the importance
of clustering analysis and available methodological and
statistical approaches for handling it, accounting for
clustering is not routine in the analysis of published
RCTs [10]. Based on findings in the general literature
[4,7,10], we hypothesized that the prevalence of the use
of clustering analysis reported in the orthopaedic litera-
ture would be low. Studies in the field of orthopaedics
often involve highly skilled therapists and therefore have
great potential to be affected by clustering [8]. The pri-
mary objective of the present study was to determine
the prevalence of reporting of the use of clustering ana-
lysis in RCTs published in the top five orthopaedic
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was to identify factors predicting the use or neglect of
use of clustering analysis in the RCTs included in this
study.
Methods
Identification of articles
We identified the top five journals with the highest 5-
year impact factor in the area of orthopaedics as listed in
the 2010 ISI Web of Knowledge Journal Citation Reports
[11]. Journals included were: American Journal of Sports
Medicine (AJSM), Journal of Bone and Joint Surgery
(JBJS), Journal of Orthopaedic Research (JOR), Osteo-
arthritis and Cartilage (OC), and The Spine Journal (SJ).
All articles in all issues of these journals published
between 2006 and 2010 were hand-searched. Inclusion
criteria for articles were: randomized allocation of partic-
ipants to two or more groups, inclusion of human sub-
jects, and inclusion of a potential grouping variable (e.g.,
multiple therapists or treatment centers). Articles were
excluded from analysis if they included nonhuman sub-
jects, if they were conducted in a single center by a
single therapist, or if they did not report enough infor-
mation to determine inclusion. A single individual
assessed all articles for inclusion (HO) and a random
proportion, approximately 10%, were checked by a sec-
ond individual (JG) to ensure eligibility. These two indi-
viduals met to discuss any disagreements, which were
resolved by discussion.
Data extraction
Articles meeting the inclusion criteria were then searched
for the following data: reporting of the number of ther-
apists delivering treatment, number of centers used in
the study, whether or not multiple therapists or centers
were accounted for in randomization or statistical ana-
lysis, year of publication, the impact factor of the jour-
nal in the publication year, whether the study team
included a statistician, whether the study team included
an epidemiologist or clinical trials methodologist, the
sample size of the study, and whether the primary out-
come (defined as the outcome described as primary, to
which the study was powered, or the first outcome re-
ported) of the study was categorically positive, neutral,
or negative. A statistician was defined as any person
with a graduate degree in statistics or biostatistics. An
epidemiologist/clinical trials methodologist was likewise
defined as any person with a graduate degree in epi-
demiology, public health, or clinical research. The cor-
responding author was contacted via e-mail and asked
if either specialist was included on the study team, if
this information was not clear from the published re-
port. The outcome of the study was defined as positive
if the study findings supported the a priori hypothesis,defined as negative if the primary outcome was in the
opposite direction hypothesized, and neutral if no sig-
nificant effect was demonstrated.
The outcome measure of interest was accounting for
clustering by therapist, accounting for clustering by cen-
ter, and accounting for any type of clustering, either in
randomization or analysis. All data were extracted by
one individual with expertise in epidemiology and
biostatistics.
Statistical analysis
Data were compiled in Excel (Microsoft, Redmond,
Washington) spreadsheets and imported into SAS, ver-
sion 9.3, statistical software (SAS Institute Inc., Cary,
North Carolina) for statistical analysis. Frequency mea-
sures were computed for all data. Logistic regression
was conducted using both univariable and multivariable
models. Univariable logistic regression was performed
for each predictor variable on each outcome variable,
with no adjustments. Multivariable models were con-
structed using stepwise deletion, with deletion of the
variable with the highest p value in each case. All vari-
ables were checked for collinearity before inclusion in
multivariable models, and collinear variables were tested
separately. Clustering effects by journal were checked
using generalized estimating equations (GEE). Odds ra-
tios and 95% confidence intervals were produced in all
analyses. An alpha level of 0.10 was considered signifi-
cant for all tests [12]. Confidence intervals reported are
at the 95% level.
Results
A total of 271 articles classified as RCTs were identified
from the five journals included in the study (Figure 1).
Thirty-two articles were excluded due to inclusion of
nonhuman subjects. The remaining 239 articles were
screened for multiple therapists and/or centers. Of these,
186 were found to include multiple centers and/or ther-
apists and were used in our analysis. Eighty-seven stud-
ies (46.7%) included multiple centers, and 145 studies
(78.0%) included multiple therapists (Table 1). Of the
186 articles included, 40 (21.5%) accounted for cluster-
ing on some level, either in randomization or statistical
analysis (see Table 2). Ninety-one studies (48.9%) re-
ported inclusion of a statistician on their study team,
and 83 (44.6%) reported inclusion of an epidemiologist
or clinical trials methodologist. However, a description
of the statistician training was missing in 60 of the stud-
ies, and data on epidemiologist/clinical trials methodolo-
gist were missing in 67 of the studies. Studies reporting
a positive outcome numbered 94 (50.5%), while negative
outcomes comprised only 6 of the studies (3.2%), and
neutral outcomes were reported in 86 (46.2%). All but
one article reported a sample size; the average sample
Figure 1 Flow chart of article inclusion.
Table 2 Methods used to account for clustering (N = 40*)
Method N (%)
Stratified randomization 23 (57.5)
Cluster randomization 7 (17.5)
GEE or controlled variable 9 (22.5)
Stratified analysis 8 (20.0)
Other 1 (2.5)
*6 studies used two or more methods to account for clustering.
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250.2), with a range of 16–2483 study participants.
Univariable logistic regression of predictors on the use
of any type of accounting for clustering is shown in
Table 3, which compares articles containing these pre-
dictors to those that do not. Three predictors were
found to have a significant association with accounting
for clustering in univariable modeling: sample size,Table 1 Characteristics of articles included in analysis
(N = 186)
N %
Multiple centers 87 46.7
Multiple therapists 145 78.0
Reported any clustering analysis 40 21.5
Reported inclusion of a statistician on study team 91 48.9
Report inclusion of a clinical trials methodologist
or epidemiologist on study team
83 44.6
Reported inclusion of either specialist 109 58.6
Reported inclusion of both specialists 65 34.9
Reported positive outcome 94 50.5
Specified null hypothesis but reported positive
outcome
31 16.7
Reported negative outcome 6 3.2
Reported neutral outcome 86 46.2
Sample size (mean, SD) 185 200.5, 344.8inclusion of an epidemiologist/clinical trials methodolo-
gist, and inclusion of any type of specialist. Trials that
accounted for clustering had 3.6 times greater odds of
including an epidemiologist/clinical trials methodologist
on their author list or research team than those that did
not account for clustering (95% CI, 1.2-11.4, P = 0.03).
Additionally, sample size appears to have a significant
association with accounting for clustering in randomiza-
tion or analysis; however, the effect size is very small (odds
ratio (OR) = > 1.0, 95% CI, 1.0-1.0, P = 0.04). The inclusion
of any type of specialist (biostatistician and/or epidemiolo-
gist) yielded a very high odds ratio, with studies account-
ing for clustering being 6.4 times more likely to include a
specialist (95% CI, 0.8-50.0, P = 0.08). All other variables
tested in univariable analysis had relatively small effect
sizes with insignificant p values (Table 3). No significant
differences were seen between individual journals in their
likelihood to account for clustering (data not shown), nor
were any significant changes seen when adjusting for clus-
tering by journal using GEEs.
Univariable logistic regression of predictors on the use
of clustering analysis to account for multiple centers is
shown in Table 4. The odds ratios for inclusion of any
type of specialist on the study team and inclusion of a
biostatistician on the study team were 2.3 and 1.9, re-
spectively; however, the 95% confidence intervals were
large and did not indicate significance. Other included
predictors had small effect estimates and none wereTable 3 Logistic regression of use of any clustering
analysis by predictors (N = 186)
OR 95% CI (P value)
Any specialist(119) 6.4 0.8-50.0 (0.08)
Both specialists(119) 2.0 0.8-4.6 (0.13)
Biostatistician(126) 1.5 0.6-3.9 (0.39)
Epidemiologist/Methodologist(119) 3.6 1.2-11.4 (0.03)
Sample size(185) 1.0 1.0-1.0 (0.04)
Journal(186) 1.2 0.9-1.6 (0.25)
Impact factor(186) 1.4 0.8-2.6 (0.23)
Outcome(186) 1.0 0.5-1.9 (0.98)
Outcome2*(186) 1.0 0.7-1.6 (0.93)
*Outcome 2 separates positive outcomes into those that specified the null
hypothesis and those that did not.
Table 4 Logistic regression of use of clustering analysis
for multiple centers by predictors (N = 87)
OR 95% CI (P value)
Any specialist(64) 2.3 0.2-20.7 (0.47)
Both specialists(58) 1.4 0.4-4.7 (0.60)
Biostatistician(64) 1.8 0.5-7.9 (0.35)
Epidemiologist/Methodologist(58) 1.1 0.3-4.9 (0.87)
Sample size(86) 1.0 1.0-1.0 (0.94)
Journal(87) 1.4 1.0-2.0 (0.07)
Impact factor(87) 1.4 0.6-2.9 (0.41)
Outcome(87) 1.3 0.6-3.0 (0.51)
Outcome2(87) 1.3 0.7-2.4 (0.38)
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variable at alpha = 0.05.
Table 5 shows univariable logistic regression of predic-
tors on the use of clustering analysis to account for mul-
tiple therapists. Again, most of the included predictors
had small effect estimates with wide confidence inter-
vals; the exception was inclusion of an epidemiologist/
clinical trials methodologist on the study team, with an
OR of 5.7. This effect estimate does have a wide confi-
dence interval, which again crosses the line of no effect,
0.7-45.9.
Multivariable models are depicted in Table 6 and
Table 7. An initial full model, Table 5, containing all var-
iables was reduced to three separate models, Table 6,
due to the significantly high collinearity of the variables
‘including any type of specialist’, ‘including a biostatisti-
cian’, and ‘including an epidemiologist/clinical trials
methodologist’. Any variables with undefined ORs were
excluded. The first model contains inclusion of an epi-
demiologist/clinical trials methodologist and is adjusted
for sample size, journals, impact factor, and outcome.
This model shows a statistically significant association,
after controlling for sample size, journal, impact factor
and outcome, between any accounting for clustering andTable 5 Logistic regression of use of clustering analysis
for multiple therapists by predictors (N = 145)
OR 95% CI (P value)
Any specialist(96) - undefined
Both specialists(96) 1.3 0.4-4.4 (0.63)
Biostatistician(101) 0.9 0.3-3.1 (0.86)
Epidemiologist/Methodologist(93) 5.7 0.7-45.9 (0.10)
Sample size(143) 1.0 1.0-1.0 (0.21)
Journal(145) 1.0 0.6-1.5 (0.85)
Impact factor(145) 1.3 0.5-3.1 (0.57)
Outcome(145) 0.7 0.3-1.7 (0.41)
Outcome2(145) 0.7 0.4-1.4 (0.35)inclusion of an epidemiologist/clinical trials methodolo-
gist, OR = 3.3 (95% CI, 1.0-10.4, P = 0.04) and separately
for inclusion any type of specialist OR = 6.7 (95% CI,
0.8-57.3, P = 0.08) but not for inclusion of a biostatisti-
cian, OR = 1.5 (95% CI, 0.6-4.1, P = 0.40). Sample size
was again seen to be significant in several of these
models; however, it consistently had a very small effect
estimate (OR = 1.0). The results of the stepwise deletion
are also shown with only epidemiologist/methodologist
and any specialist remaining in the model.
Discussion
Our study on the use of clustering analysis in ortho-
paedic research suggests that a small proportion of stud-
ies are currently employing these important statistical
methods. Multivariable modeling of predictors associ-
ated with the presence of adjustment for clustering
showed a strong and significant association between any
type of clustering adjustment and inclusion of an epi-
demiologist/clinical trials methodologist on the study
team.
Our study has several strengths and weaknesses. First,
we systematically identified every RCT published in the
top five journals of orthopaedic surgery between 2006
and 2010. This method of limiting to specific journals
allowed for the entire target population of articles to be
identified, as opposed to an electronic literature search
that may miss potential articles meeting the inclusion
criteria. Use of the top five journals also allows the as-
sumption of a conservative estimate in our findings. But
on the other hand, this cannot be generalized to other
journals or to the broader orthopaedic literature. Also,
while a single individual did inclusion for all articles, a
second individual cross-checked a random selection of
articles, which minimizes any selection bias.
Identified articles were then reviewed for inclusion
and relevant data were extracted by a single researcher
with experience in epidemiology and biostatistics. This
extraction method allowed for consistency across articles
and maintained homogenous definitions throughout the
process; however, while there may be potential for bias
due to extraction by a single reviewer, both authors met
throughout the extraction process to clarify interpreta-
tions of extracted data. Despite efforts to extract all rele-
vant data from all articles in the target population, data
were underreported in several of the articles. Missing
data were especially notable for the variables “biostatisti-
cian” and “epidemiologist/clinical trials methodologist”;
the majority of author or study member specialties were
not reported in the articles or easily identifiable from
headings. In an effort to minimize the missing data, the
corresponding author of each article was contacted and
asked about the specialties of members of the study
team. However, not all authors responded to the request
Table 6 Multivariable analysis of any use of clustering analysis, stepwise deletion
Model 1 OR(CI),
P value
Model 2 OR(CI),
P value
Model 3 OR(CI),
P value
Model 4 OR(CI),
P value
Model 5 OR(CI),
P value
Model 6 OR(CI),
P value
Any specialist 3.9(0.3-60.3), 0.32 3.5(0.3-40.8), 0.32 3.5(0.3-40.8), 0.32 3.6(0.3-42.5), 0.31 3.7(0.3-42.9), 0.30
Biostatistician 0.9(0.3-2.8), 0.84
Epidemiologist/Methodologist 2.0(0.5-8.1), 0.32 2.1(0.5-8.0), 0.29 2.1(0.5-8.1), 0.28 2.1(0.5-7.8), 0.29 2.0(0.5-7.7), 0.30 3.3(1.0-10.4), 0.04
Sample size 1.0(1.0-1.0), 0.05 1.0(1.0-1.0), 0.05 1.0(1.0-1.0), 0.05 1.0(1.0-1.0), 0.06 1.0(1.0-1.0), 0.06 1.0(1.0-1.0), 0.07
Journal 1.1(0.8-1.6), 0.55 1.1(0.8-1.6), 0.54 1.1(0.8-1.6), 0.50 1.1(0.8-1.6), 0.57
Impact factor 1.1(0.5-2.4), 0.84 1.1(0.5-2.4), 0.85
Outcome 0.8(0.3-1.8), 0.58 0.8(0.3-1.8), 0.55 0.8(0.3-1.7), 0.54
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One possibility is that studies not reporting study mem-
ber specialties may have been less likely to perform clus-
tering analysis. If this was the case, our study would
represent the higher-quality articles and therefore poten-
tially be an over estimate of the use of clustering ana-
lysis. This hypothesis remains to be tested.
The method of stepwise regression used in the analysis
of these data is controversial in some contexts, but gen-
erally remains an accepted method of hypothesis testing
and generation. We are not aware of any other literature
investigating predictors of accounting for clustering, and
the investigational nature of this objective led us to this
approach. Further studies are needed to verify these
findings. Furthermore, the method of using GEEs for ac-
counting for clustering in our analyses has recently been
shown in Poisson data to increase the likelihood of type
1 errors [13], but not in binary outcomes. That is, in an-
other paper Monte Carlo simulations showed that GEE
models had better power at detecting within-clusterTable 7 Multivariable analysis of any use of clustering analys
deletion for each specialist variable
Model 1 OR(CI), P value Model 2 OR
Epidemiologist/Methodologist 3.3(1.0-10.6), 0.04 3.3(1.0-10.7),
Sample size 1.0(1.0-1.0), 0.06 1.0(1.0-1.0), 0
Journal 1.1(0.8-1.6), 0.50 1.1(0.8-1.6), 0
Impact factor 1.1(0.5-2.3), 0.89
Outcome 0.8(0.3-1.7), 0.51 0.8(0.3-1.7), 0
Biostatistician 1.5(0.6-4.1), 0.40 1.5(0.6-4.1), 0
Sample size 1.0(1.0-1.0), 0.03 1.0(1.0-1.0), 0
Journal 1.2(0.8-1.6), 0.36 1.2(0.8-1.7), 0
Impact factor 1.2(0.6-2.5), 0.61
Outcome 0.8(0.4-1.7), 0.49 0.8(0.3-1.6), 0
Any specialist 6.7(0.8-57.3), 0.08 6.9(0.8-58.8),
Sample size 1.0(1.0-1.0), 0.03 1.0(1.0-1.0), 0
Journal 1.2(0.8-1.6), 0.39 1.1(0.8-1.6), 0
Impact factor 1.2(0.6-2.7), 0.58 1.3(0.6-2.7), 0
Outcome 0.8(0.4-1.8), 0.60homogeneity than did other methods when examining
binary outcomes [14]. We recommend additional simu-
lations be carried out to determine the validity of this
approach.
A final potential weakness of the study is the cut-off
date of 2010. It is possible that in the year and a half be-
tween our cut-off date and the analysis of these data,
levels of the use of clustering analysis in orthopaedic
RCT studies have changed. However, there is no known
identifiable event that would initiate such a change,
making this a marginal concern. Overall, our analysis is
only applicable to the year of papers we reviewed for
these journals. But, we still hold that this analysis repre-
sents relatively recent RCTs in orthopaedic surgery and
their use of clustering analyses.
Although several papers have previously demonstrated
the importance of taking clustering into account in
RCTs, this type of analysis has not yet become standard
practice [7,10]. Our study suggests a low prevalence of
adjustment for clustering effects in RCTs published inis after elimination of collinear variables, stepwise
(CI), P value Model 3 OR(CI), P value Model 4 OR(CI), P value
0.04 3.3(1.0-10.5), 0.04 3.3(1.0-10.4), 0.04
.05 1.0(1.0-1.0), 0.06 1.0(1.0-1.0), 0.07
.46 1.1(0.8-1.6), 0.55
.50
.40 1.5(0.6-4.0), 0.42
.03 1.0(1.0-1.0), 0.04 1.0(1.0-1.0), 0.04
.28 1.2(0.8-1.6), 0.34 1.2(0.9-1.5), 0.29
.48
0.08 7.0(0.8-61.0), 0.08 7.0(0.8-60.7), 0.08
.04 1.0(1.0-1.0), 0.03 1.0(1.0-1.0), 0.04
.44 1.2(0.8-1.6), 0.33
.55
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articles using any of these important methods. To the
best of our knowledge, our study is the first to look at
potential predictors of the use of clustering adjustment
in RCTs. Multivariable modeling of predictors associated
with adjustment for clustering showed a strong and sig-
nificant association between any type of clustering ad-
justment and inclusion of an epidemiologist/clinical
trials methodologist on the study team. A large effect
was also seen for the inclusion of any type of specialist
(epidemiologist/clinical trials methodologist or biostatis-
tician). This finding was expected, in that individuals
specifically trained in clinical research methods are more
likely to employ proper methodology. By demonstrating
the association between an adjustment for clustering in
a study and the presence of an epidemiologist or clinical
trials methodologist on the study team, we are able to
make recommendations for practical ways to improve
the use of these important statistical methods. For ex-
ample, the inclusion of an epidemiologist or clinical re-
search methodologist in the study design phase a priori
could ensure that proper methods are planned and im-
plemented that limit or control for the effects of cluster-
ing (e.g., stratification, limiting the number of centers/
providers, homogeneous cluster sizes, statistical analyses
to adjust for clustering).
We were surprised to find that the inclusion of a bio-
statistician was not significantly associated with in-
creased use of clustering adjustment methods. One
potential explanation is that epidemiologists or clinical
trial methodologists are often included from the design
phase of a study, whereas biostatisticians are often only
included in the analysis phase. Since our outcome is de-
fined as accounting for clustering effects in either
randomization or statistical analysis, involvement of a
specialist a priori in the study is an important consider-
ation. This a priori versus ad hoc inclusion may be
associated with a greater use of proper adjustment
techniques; however, this hypothesis remains to be
tested.
In addition to a lack of proper author specialization on
study teams, there are several other potential reasons
that adjustment for clustering effects is not currently a
common practice. As mentioned above, adjustment for
clustering generally increases the sample size needed for
a given power, making recruitment a longer or more dif-
ficult process and potentially increasing funding and
other resource needs. This could act as a barrier to re-
searchers who might initially be interested in examining
clustering effects within their studies. We found that
many of the included studies reported that the therapists
had similar training or that there were no noted differ-
ences between therapists. But this is insufficient, as clus-
tering effects may still exist and equality of therapistscannot be assumed. We recommend that clinical trialists
perform these analyses where relevant and that institu-
tional review boards and peer reviewers be careful to
point out the need for these analyses. In addition, a set
of standards could be developed that outline when and
how these adjustments can be done, providing concrete
examples and empirical evidence of this need.
The effect of clustering may be difficult to detect in
studies that are underpowered when divided by cluster;
however, statistical analyses that ignore the presence of
potential clustering will most likely result in overly pre-
cise and therefore misleading estimates [1]. The methods
for performing sample size calculations for studies with
clustering effects depend on the type of data for the pri-
mary outcome of interest (e.g., continuous, binary,
count). Several methods are suggested in the literature
and several statistical packages have the ability to derive
these estimates [15,16]. As an example, many studies use
outcome measures that produce continuous data, for
which an ICC is needed to calculate sample size; this re-
quires an a priori knowledge of within- and between-
cluster variances [17]. Several efforts are underway to
encourage the use of clustering analysis through the cre-
ation of databases of ICCs for various outcomes used in
surgical trials [1]. These databases will give researchers
information on the likely magnitude of ICCs for differ-
ent outcomes and enable the use of clustering effect esti-
mates in the planning stages of a trial. This in turn will
enable accurate sample size calculation in the design
phase of a study and thus adequate power to test hy-
potheses [18]. Cook et al. [1] suggest that the optimal
use of available data would involve a formal meta-
analysis of ICC estimates. Furthermore, more work is
needed on sample size calculations and methods of ac-
counting for clustering for binary and count data in clin-
ical research. This important research should be
prioritized, with the goal of informing researchers of
possible clustering effects by outcome and enabling bet-
ter practices in analyses through a priori understanding
of potential clustering effects.Conclusions
On the basis of our findings, we see a need for the im-
provement in methodology when dealing with clustering
in RCTs. Strongly associated with adjusting for cluster-
ing was the inclusion on the study team of a specialist in
biostatistics and/or epidemiology/clinical trials method-
ology. Investigators planning RCTs should make careful
selection of their study teams to ensure that proper ex-
pertise is included. Additionally, the use of databases
categorizing ICCs for different outcomes from the plan-
ning stages of a trial will improve sampling and study
design and help reduce the effects of clustering.
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